Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
August 6, 2025
Gasping for Strength
Daniel Zarhin, Hadar Kolb, Avi Gadoth
International Journal of Molecular Sciences
|
January 11, 2022
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
Ido Ben-Shalom, Arnon Karni, Hadar Kolb
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 29, 2012
Role of immunosuppressive therapy for the treatment of multiple sclerosis
James M Stankiewicz, Hadar Kolb, Arnon Karni, et al.
Clinical Neurology and Neurosurgery
|
July 31, 2023
Olfactory function in Susac syndrome
Yoav Piura, Arnon Karni, Hadar Kolb, et al.
Journal of Neuroimmunology
|
May 13, 2017
Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel
Ali Asmail, Anat Kesler, Vivian E Drory, et al.
Journal of Neuroimmunology
|
September 10, 2016
Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms
Arnon Karni, Ali Asmail, Vivian E Drory, et al.
Magnetic Resonance in Medicine
|
June 26, 2024
Reducing blood flow pulsation artifacts in 3D time-of-flight angiography by locally scrambling the order of the acquisition at 3 T and 7 T
Amir Seginer, Dana Niry, Edna Furman-Haran, et al.
The International Journal of Neuroscience
|
September 28, 2018
A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences
Ali Asmail, Anat Kesler, Hadar Kolb, et al.
Eneurologicalsci
|
February 13, 2018
Characterization of patients with ocular myasthenia gravis - A case series
Arnon Karni, Ali Asmail, Vivian E Drory, et al.
Journal of Neuroimmunology
|
August 24, 2015
Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels
Karin Mausner-Fainberg, Keren Regev, Hadar Kolb, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
August 6, 2025
Gasping for Strength
Daniel Zarhin, Hadar Kolb, Avi Gadoth
International Journal of Molecular Sciences
|
January 11, 2022
The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
Ido Ben-Shalom, Arnon Karni, Hadar Kolb
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 29, 2012
Role of immunosuppressive therapy for the treatment of multiple sclerosis
James M Stankiewicz, Hadar Kolb, Arnon Karni, et al.
Clinical Neurology and Neurosurgery
|
July 31, 2023
Olfactory function in Susac syndrome
Yoav Piura, Arnon Karni, Hadar Kolb, et al.
Journal of Neuroimmunology
|
May 13, 2017
Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel
Ali Asmail, Anat Kesler, Vivian E Drory, et al.
Journal of Neuroimmunology
|
September 10, 2016
Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms
Arnon Karni, Ali Asmail, Vivian E Drory, et al.
Magnetic Resonance in Medicine
|
June 26, 2024
Reducing blood flow pulsation artifacts in 3D time-of-flight angiography by locally scrambling the order of the acquisition at 3 T and 7 T
Amir Seginer, Dana Niry, Edna Furman-Haran, et al.
The International Journal of Neuroscience
|
September 28, 2018
A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences
Ali Asmail, Anat Kesler, Hadar Kolb, et al.
Eneurologicalsci
|
February 13, 2018
Characterization of patients with ocular myasthenia gravis - A case series
Arnon Karni, Ali Asmail, Vivian E Drory, et al.
Journal of Neuroimmunology
|
August 24, 2015
Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels
Karin Mausner-Fainberg, Keren Regev, Hadar Kolb, et al.
Page
of 3